Bifidumbacterin, lyophilizate 5 doses 10 pcs

Diarrhea, Colitis, Bloating, Dysbacteriosis, Intestinal infections, Constipation

In diseases of the gastrointestinal tract:

• for the treatment of long-term intestinal dysfunction of unspecified etiology;
• in acute intestinal infections (in the complex treatment of acute dysentery, salmonellosis, escherichiosis, viral diarrhea, etc.п.), prolonged intestinal dysfunctions of staphylococcal aetiology as well as for treatment of relapsed patients after acute intestinal infections with continued intestinal dysfunction;
• . In complex treatment of children (including infants, prematurely born) with pneumonia, sepsis and other purulent-infectious diseases, for prevention or relief of intestinal dysfunction and prevention of ulcerous-necrotic enterocolitis development;

.

• for treatment and prevention of dysbacteriosis in children with a history of premorbid conditions, born prematurely or with signs of prematurity who received antibiotics in the early neonatal period; Children whose mothers have had severe toxicosis, extragenital diseases, prolonged waterless period or other pathologies; children of mothers who have had lactastasis, cracked nipples and resume breastfeeding after recovery from mastitis; Weakened children with anaemia, hypotrophy, rickets, diathesis, and other manifestations of allergy; whooping cough-especially if they have any bowel dysfunction;
• In early transition to complementary feeding or donor milk;
• For infants for the treatment of acute and chronic inflammatory diseases of the large and small intestine (colitis, enterocolitis) in older children and adults, occurring against a background of microflora disorders with a deficit or absence of Bifidobacterium in intestinal dysfunction as a result of dysbacteriosis of the intestine, resulting from prolonged antibacterial, hormonal, radiation and other therapy, in stressful situations and under extreme conditions, as well as for the prevention of dysbacteriosis in these individuals.

In obstetric and gynecological practice:

• for the prevention of mastitis for local treatment of the mammary glands of nursing mothers of the “risk” group (in women with retracted flat nipple, with a decrease in its erection, the presence of fissures) in a burdened epidemiological situation in maternity hospitals;
• in violation of purity of vaginal secretion to degree III – IV in pregnant women of “risk” group;
• in bacterial colpitis caused by Staphylococcus and E. coli (in monoflora or in associations), as well as in senile colpitis of hormonal nature.

.

Active ingredient

Bifidobacterium bifidum

Composition

One dose of the drug contains live bifidobacteria at least 10⁷.

Assisted substances:

Lactulose – 2%, components of the drying medium: sucrose, gelatin, skim milk (skim).

How to take, the dosage

Bifidumbacterin in intestinal diseases is used orally, and in obstetric and gynecological practice: topically (intravaginal).

1. treatment and prevention of gastrointestinal diseases:

The contents of the bottle should be dissolved with boiled water at room temperature at the rate of 5 ml (teaspoon) of water per 1 dose of the drug.

Dissolve as follows: pour the necessary amount of water into a glass (according to the number of doses indicated on the bottle); open the bottle by removing the cap and cork; from the glass transfer a small amount of water into the bottle; after dissolution (the drug dissolves in less than 5 minutes, forming an opaque homogenous suspension) transfer the contents of the bottle into the same glass and stir. One teaspoon of the drug dissolved in this way makes 1 dose. The dissolved drug should not be stored.

The required number of doses (teaspoons, respectively) should be taken 20-30 minutes before a meal or 1-1.5 hours after the meal. Infants can be given the drug immediately before feeding.

In case of intestinal diseases: to children of the first half of the life cycle the drug is prescribed in 5 doses for 2 times a day, to children of the second half of the life cycle and older in 5 doses 3 times a day.

In newborns of the “risk” group it is reasonable to start using the drug in the maternity department from the first day of life until discharge in 2.5 doses per administration twice a day.

In children with sepsis, pneumonia and other purulent-infectious diseases 5 doses 3 times a day are prescribed in combination with usual methods of treatment of the main disease. In case of gastrointestinal dysfunction and the threat of ulcerative necrotic enterocolitis in this group of children the dosage of Bifidumbacterin is increased to 20 doses daily.

In acute and chronic inflammatory diseases of the small and large intestine, children over 3 years of age and adults are recommended to take 5 doses 2-3 times a day. In severe cases of the disease, the dose can be doubled.

The duration of treatment with Bifidumbacterin is determined by the severity of the clinical manifestations, the age of the patient and is 2-4 weeks, and in some cases up to 3 months.

For preventive purposes the drug is prescribed in 5 doses 1-2 times a day for 1-2 weeks.

2. In obstetrical-gynecological practice:

For the treatment of the nipple and areola of parturient women the content of one bottle (5 doses) is dissolved in cold boiled water and 2 sterile swabs are soaked in the solution and applied for 20-30 minutes before each feeding within 5 days. The swab impregnated with the preparation is left on the surface of the mammary gland until the beginning of feeding.

In case of inflammatory diseases of the female genitalia and in prenatal preparation of the pregnant women of the “risk” group Bifidumbacterin is prescribed in 5-10 doses once a day for 5-8 days with the control of restoration of purity of vaginal secretion to I-II degree and disappearance of clinical symptoms.

For intravaginal administration Bifidumbacterin is also dissolved by the above method. The resulting suspension of the drug is soaked in a sterile tampon, which, without wringing, is inserted intravaginally and left for 2-3 hours.

If necessary, the treatment with Bifidumbacterin can be repeated.

Interaction

Clinically significant interaction of the drug with other drugs has not been established. Bifidumbacterin can be used simultaneously with antibacterial, antiviral and immunomodulatory therapy. The effect is enhanced by vitamins (especially B-group), reduced-antibiotics. Corrective therapy with bifidumbacterin can be prescribed after a course of treatment with specific bacteriophages designed to eliminate opportunistic bacteria.

Special Instructions

The drug does not affect the performance of activities requiring special attention and quick reactions (driving vehicles, machinery, etc.).

Synopsis

Crystalline or porous mass with possible stratification of the biomass in the upper part, beige or whitish-gray in color, with a specific smell.

Pregnancy use

Bifidobacteria are representatives of normal human microflora, so preparations based on them can be used during pregnancy and lactation.

Similarities

Bifidumbacterin forte